Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Reata Pharma (NQ: RETA ) N/A UNCHANGED Last Price Updated: 4:00 PM EDT, Sep 25, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Reata Pharma < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Benzinga's Top Ratings Upgrades, Downgrades For June 12, 2023 June 12, 2023 Via Benzinga Bragar Eagel & Squire, P.C. Is Investigating Reata, Comerica, and DZS and Encourages Investors to Contact the Firm June 09, 2023 From Bragar Eagel & Squire Via GlobeNewswire Reata Pharmaceuticals Stock Plummets More Than 20%: Here's Why May 10, 2023 Reata Pharmaceuticals Inc (NASDAQ: RETA) and its partner Kyowa Kirin Co Ltd have decided to discontinue Via Benzinga Reata Pharma Tumbles After Scrapping Its Kidney Drug As Earnings Come In Mixed May 10, 2023 Reata scrapped development of bardoxolone in chronic kidney disease. Via Investor's Business Daily Recap: Reata Pharmaceuticals Q1 Earnings May 10, 2023 Via Benzinga Earnings Outlook For Reata Pharmaceuticals May 09, 2023 Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session June 09, 2023 Via Benzinga NASDAQ:RETA Investor Alert: Investigation over Possible Securities Laws Violations by Reata Pharmaceuticals, Inc. June 07, 2023 San Diego, CA -- (SBWIRE) -- 06/07/2023 -- Reata Pharmaceuticals, Inc. is under investigation over potential securities laws violations in connection with certain financial statements. Via SBWire Reata Pharmaceuticals Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference June 06, 2023 From Reata Pharmaceuticals, Inc. Via Business Wire Bragar Eagel & Squire, P.C. Is Investigating Phathom, Reata, and Comerica and Encourages Investors to Contact the Firm June 04, 2023 From Bragar Eagel & Squire Via GlobeNewswire Reata Pharmaceuticals Inc. (NASDAQ: RETA) is a Stock Spotlight on 5/5 May 05, 2023 Via Investor Brand Network Where Reata Pharmaceuticals Stands With Analysts April 13, 2023 Via Benzinga The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree June 02, 2023 Big Pharma is facing a patent cliff that could siphon off billions in revenue. Via Investor's Business Daily How Biohaven Is Coming 'Out Of Stealth Mode' — And Bullishly Extending A 4-Day Run June 01, 2023 Shares surged into and out of the company's R&D Day, which included a surprise. Via Investor's Business Daily REATA ALERT: Bragar Eagel & Squire, P.C. is Investigating Reata Pharmaceuticals, Inc. on Behalf of Reata Stockholders and Encourages Investors to Contact the Firm May 26, 2023 From Bragar Eagel & Squire, P.C. Via Business Wire Where Reata Pharmaceuticals Stands With Analysts March 27, 2023 Via Benzinga 2 Top Healthcare Stocks Defying the Bear Market March 07, 2023 These two healthcare stocks have been swimming against the current. Via The Motley Fool Abercrombie & Fitch, Urban Outfitters, Photronics And Other Big Stocks Moving Higher On Wednesday May 24, 2023 U.S. stocks traded lower, with the Dow Jones dropping around 200 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga 10 Health Care Stocks With Whale Alerts In Today's Session May 12, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session May 10, 2023 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday May 10, 2023 It's time for another dive into the biggest pre-market stock movers as we see what shares are on rising and falling on Tuesday! Via InvestorPlace Why MBIA Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session May 10, 2023 Gainers Unique Fabricating, Inc. (NYSE: UFAB) climbed 205% to $0.55 after gaining around 4% on Tuesday. Via Benzinga Reata Pharmaceuticals, Inc. Announces First Quarter 2023 Financial Results and Provides an Update on Operational Progress and Clinical Development Programs May 10, 2023 From Reata Pharmaceuticals, Inc. Via Business Wire 10 Health Care Stocks With Whale Alerts In Today's Session May 08, 2023 Via Benzinga Reata Pharmaceuticals, Inc. to Report First Quarter 2023 Financial Results and to Provide an Update on Operational Progress and Clinical Development Programs on May 10, 2023 May 02, 2023 From Reata Pharmaceuticals, Inc. Via Business Wire 3 Stocks That Already Doubled in 2023 and Could Keep Climbing April 11, 2023 The gains these stocks notched in the first few months of the year could be the beginning of a much longer bull run. Via The Motley Fool REATA PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Reata Pharmaceuticals, Inc. - RETA March 31, 2023 From Kahn Swick & Foti, LLC Via Business Wire The 3 Best Growth Stocks to Buy in the Biotech Sector March 29, 2023 These three biotech growth stocks are brimming with potential and could offer massive upside for patient investors. Via InvestorPlace 3 Supercharged Stocks Near 52-Week Highs That Could Keep Climbing March 19, 2023 The high-flyers have soared to new heights and further gains could be up ahead. Via The Motley Fool The Stock That Tripled in a Day...And May Not Be Done March 07, 2023 Reata Pharmaceuticals now has a long-coveted commercialized drug in its portfolio. Should investors covet this biotech stock for their portfolios? Via MarketBeat < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.